We could confirm this expression pattern by investigating CCR7 expression in publicly available RNA sequencing datasets from TCGA [34] and GTEx [35], where ACC again had lower expression of CCR7, as well as its ligands CCL19 and CCL21 compared to normal adrenal glands (Figure 3B). This evidence concerns the gene CCL21 and adrenal cortex carcinoma.